Patents by Inventor Ludmila Globa

Ludmila Globa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230090162
    Abstract: A pharmaceutical composition comprises a metal nanoparticle having an average diameter of about 0.5 nm to about 5 nm. The composition may be used to treat cancer or an anosmia-related disease.
    Type: Application
    Filed: November 16, 2022
    Publication date: March 23, 2023
    Inventors: Vitaly VODYANOY, Oleg PUSTOVYY, Ludmila GLOBA, Mahmoud MANSOUR, Iryna SOROKULOVA
  • Publication number: 20210000868
    Abstract: A pharmaceutical composition comprises a metal nanoparticle having an average diameter of about 0.5 nm to about 5 nm. The composition may be used to treat cancer or an anosmia-related disease.
    Type: Application
    Filed: September 21, 2020
    Publication date: January 7, 2021
    Inventors: Vitaly VODYANOY, Oleg PUSTOVYY, Ludmila GLOBA, Mahmoud MANSOUR, Iryna SOROKULOVA
  • Patent number: 10806754
    Abstract: A pharmaceutical composition comprises a metal nanoparticle having an average diameter of about 0.5 nm to about 5 nm. The composition may be used to treat cancer or an anosmia-related disease.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: October 20, 2020
    Assignee: Auburn University
    Inventors: Vitaly Vodyanoy, Oleg Pustovyy, Ludmila Globa, Mahmoud Mansour, Iryna Sorokulova
  • Publication number: 20180271904
    Abstract: A pharmaceutical composition comprises a metal nanoparticle having an average diameter of about 0.5 nm to about 5 nm. The composition may be used to treat cancer or an anosmia-related disease.
    Type: Application
    Filed: March 21, 2018
    Publication date: September 27, 2018
    Inventors: Vitaly VODYANOY, Oleg PUSTOVYY, Ludmila GLOBA, Mahmoud MANSOUR, Iryna SOROKULOVA
  • Publication number: 20050260133
    Abstract: A diagnostic technique for matching anti-cancer peptide drugs to the molecular profiles of individual cancer tumors, and a method using the technique for a patient-specific treatment of tumors in mammals. This strategy matches anti-cancer peptide drugs to the molecular profiles of individual tumors, and includes the development of two banks, both of which use the same targeting peptides. Targeting peptides are identified using biopsies or other tissue materials from multiple cancer patients and placed into two banks. For a bank of probes, targeting peptides are linked to a label such as a fluorescent or a radioisotope. For a bank of drugs, targeting peptides are linked to a cytotoxic peptide to form a “targeting peptide drug”. Peptide probes are used to establish molecular profiles of individual tumors. Based on these molecular profiles, a patient-specific combination of targeting drugs from the bank of peptide drugs is prepared and the patient is treated.
    Type: Application
    Filed: May 19, 2005
    Publication date: November 24, 2005
    Inventors: Tatiana Samoylova, Henry Baker, Nancy Cox, Vitaly Vodyanoy, Ludmila Globa, Nancy Morrison